Loading clinical trials...

A Pilot Study Evaluating Heart and Lung Metabolism in Pulmonary Hypertension Associated With Left Heart Disease | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNANCT02237378

A Pilot Study Evaluating Heart and Lung Metabolism in Pulmonary Hypertension Associated With Left Heart Disease

Right ventricular (RV) failure is the leading cause of death in pulmonary arterial hypertension. (PAH) Right ventricular ejection fraction is one of the most important predictors of prognosis in heart...

Lead sponsor: Ottawa Heart Institute Research Corporation•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1/2

Feasibility of Semaglutide in Advanced Lung Disease

NCT05746039 · Obesity, Interstitial Lung Disease, and more

RECRUITINGNA

Development of Novel Physiological CMR Methods in Health and Disease

NCT03854071 · Heart Failure, Pulmonary Hypertension, and more

RECRUITINGPhase 2

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

NCT07073820 · Pulmonary Hypertension

RECRUITING

Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders

NCT07477197 · Adult Congenital Heart Disease, Pulmonary Hypertension, and more

RECRUITINGPhase 1

Preliminary Human Trials of F230 Tablets

NCT06899815 · Pulmonary Hypertension

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 31, 2018Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment2

Start dateDec 2014

Last updatedAug 31, 2018

Condition

Pulmonary Hypertension

Locations shown

University of OttawaHeart Institute

Ottawa, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 31, 2018Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions